According to Sonoma Pharmaceuticals's latest financial reports the company's total debt is โน26.42 Million. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2024-03-31 | โน50.68 M | -27.33% |
2023-03-31 | โน69.75 M | -32.78% |
2022-03-31 | โน0.10 B | -47.01% |
2021-03-31 | โน0.19 B | 205.84% |
2020-03-31 | โน64.02 M | 94.14% |
2019-03-31 | โน32.97 M | -8.4% |
2018-03-31 | โน36 M | 35.39% |
2017-03-31 | โน26.59 M | 252.11% |
2016-03-31 | โน7.55 M | 39.32% |
2015-03-31 | โน5.42 M | -38.53% |
2014-03-31 | โน8.81 M | -91.6% |
2013-03-31 | โน0.10 B | -36.23% |
2012-03-31 | โน0.16 B | 45.58% |
2011-03-31 | โน0.11 B | 707.78% |
2010-03-31 | โน14 M | -17.29% |
2009-03-31 | โน16.93 M | -81% |
2008-03-31 | โน89.12 M | -74.44% |
2007-03-31 | โน0.34 B | 910.13% |
2006-03-31 | โน34.52 M | -46.97% |
2005-03-31 | โน65.1 M |
Company | Total debt/th> | differencediff. | Country |
---|---|---|---|
![]() Onconova Therapeutics ONTX | N/A | N/A | ๐บ๐ธ USA |
![]() OPKO Health
OPK | โน42.70 B | 161,502.95% | ๐บ๐ธ USA |